Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Immunogenicity and adverse events of SARS-CoV-2 vaccine in health workers].
Juárez V, Marina G, Ramón C, Parentis M, Mamaní L, Rúa GA, Crespo Espindola ME, Buschiazzo EA, Aciar MM, Belbruno LN, Lecumberri MB, Ralle AC, Luna Murillo JM, Delgado L, Miranda Cáceres I, Bonnal JP, Guzman VE, Eddelcop BA. Juárez V, et al. Among authors: lecumberri mb. Medicina (B Aires). 2024;84(3):496-504. Medicina (B Aires). 2024. PMID: 38907964 Free article. Spanish.
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.
Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos-Ruiz R, Dittmann A, Nanni P, Fresno Vara JÁ, Espinosa E. Trilla-Fuertes L, et al. Among authors: lecumberri mj. Cancers (Basel). 2023 Sep 3;15(17):4407. doi: 10.3390/cancers15174407. Cancers (Basel). 2023. PMID: 37686682 Free PMC article.
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.
Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Zapater-Moros A, López-Camacho E, Lumbreras-Herrera MI, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos R, Fresno Vara JÁ, Espinosa E. Trilla-Fuertes L, et al. Among authors: lecumberri mj. Int J Mol Sci. 2023 Jan 2;24(1):801. doi: 10.3390/ijms24010801. Int J Mol Sci. 2023. PMID: 36614248 Free PMC article.
Ethical Decision Making in Iot Data Driven Research: A Case Study of a Large-Scale Pilot.
Segkouli S, Fico G, Vera-Muñoz C, Lecumberri M, Voulgaridis A, Triantafyllidis A, Sala P, Nunziata S, Campanini N, Montanari E, Morton S, Duclos A, Cocchi F, Nava MD, de Lorenzo T, Chalkia E, Loukea M, Colomer JBM, Dafoulas GE, Guillén S, Arredondo Waldmeyer MT, Votis K. Segkouli S, et al. Among authors: lecumberri m. Healthcare (Basel). 2022 May 23;10(5):957. doi: 10.3390/healthcare10050957. Healthcare (Basel). 2022. PMID: 35628094 Free PMC article.
Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO).
Rubio MJ, Lecumberri MJ, Varela S, Alarcón J, Ortega ME, Gaba L, Espinós J, Calzas J, Barretina P, Ruiz I, Marquina G, Santaballa A. Rubio MJ, et al. Among authors: lecumberri mj. Gynecol Oncol Rep. 2020 Jun 4;33:100594. doi: 10.1016/j.gore.2020.100594. eCollection 2020 Aug. Gynecol Oncol Rep. 2020. PMID: 32566719 Free PMC article.
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.
Zuazo M, Arasanz H, Fernández-Hinojal G, García-Granda MJ, Gato M, Bocanegra A, Martínez M, Hernández B, Teijeira L, Morilla I, Lecumberri MJ, Fernández de Lascoiti A, Vera R, Kochan G, Escors D. Zuazo M, et al. Among authors: lecumberri mj. EMBO Mol Med. 2019 Jul;11(7):e10293. doi: 10.15252/emmm.201910293. Epub 2019 Jun 6. EMBO Mol Med. 2019. PMID: 31273938 Free PMC article.
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.
Bocanegra A, Fernandez-Hinojal G, Zuazo-Ibarra M, Arasanz H, Garcia-Granda MJ, Hernandez C, Ibañez M, Hernandez-Marin B, Martinez-Aguillo M, Lecumberri MJ, Fernandez de Lascoiti A, Teijeira L, Morilla I, Vera R, Escors D, Kochan G. Bocanegra A, et al. Among authors: lecumberri mj. Int J Mol Sci. 2019 Apr 2;20(7):1631. doi: 10.3390/ijms20071631. Int J Mol Sci. 2019. PMID: 30986912 Free PMC article.
Immunotherapy in malignant melanoma: recent approaches and new perspectives.
Arasanz H, Lacalle A, Lecumberri MJ, de Lascoiti ÁF, Blanco-Luquin I, GatoCañas M, Pérez-Ricarte L, Zuazo M, Kochan G, Escors D. Arasanz H, et al. Among authors: lecumberri mj. Melanoma Manag. 2017 Mar;4(1):39-48. doi: 10.2217/mmt-2016-0019. Epub 2017 Mar 1. Melanoma Manag. 2017. PMID: 30190903 Free PMC article. Review.
24 results